301 related articles for article (PubMed ID: 21397859)
1. The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma.
Mehta S; Huillard E; Kesari S; Maire CL; Golebiowski D; Harrington EP; Alberta JA; Kane MF; Theisen M; Ligon KL; Rowitch DH; Stiles CD
Cancer Cell; 2011 Mar; 19(3):359-71. PubMed ID: 21397859
[TBL] [Abstract][Full Text] [Related]
2. Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting.
Liu H; Weng W; Guo R; Zhou J; Xue J; Zhong S; Cheng J; Zhu MX; Pan SJ; Li Y
Cell Death Differ; 2020 Nov; 27(11):3146-3161. PubMed ID: 32483381
[TBL] [Abstract][Full Text] [Related]
3. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.
Ligon KL; Huillard E; Mehta S; Kesari S; Liu H; Alberta JA; Bachoo RM; Kane M; Louis DN; Depinho RA; Anderson DJ; Stiles CD; Rowitch DH
Neuron; 2007 Feb; 53(4):503-17. PubMed ID: 17296553
[TBL] [Abstract][Full Text] [Related]
4. An amino terminal phosphorylation motif regulates intranuclear compartmentalization of Olig2 in neural progenitor cells.
Meijer DH; Sun Y; Liu T; Kane MF; Alberta JA; Adelmant G; Kupp R; Marto JA; Rowitch DH; Nakatani Y; Stiles CD; Mehta S
J Neurosci; 2014 Jun; 34(25):8507-18. PubMed ID: 24948806
[TBL] [Abstract][Full Text] [Related]
5. Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells.
Kupp R; Shtayer L; Tien AC; Szeto E; Sanai N; Rowitch DH; Mehta S
Cell Rep; 2016 Sep; 16(11):2838-2845. PubMed ID: 27626655
[TBL] [Abstract][Full Text] [Related]
6. Ddx20, an Olig2 binding factor, governs the survival of neural and oligodendrocyte progenitor cells via proper Mdm2 splicing and p53 suppression.
Bizen N; Bepari AK; Zhou L; Abe M; Sakimura K; Ono K; Takebayashi H
Cell Death Differ; 2022 May; 29(5):1028-1041. PubMed ID: 34974536
[TBL] [Abstract][Full Text] [Related]
7. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract][Full Text] [Related]
8. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.
Havrda MC; Paolella BR; Ran C; Jering KS; Wray CM; Sullivan JM; Nailor A; Hitoshi Y; Israel MA
Cancer Res; 2014 Mar; 74(6):1822-32. PubMed ID: 24425046
[TBL] [Abstract][Full Text] [Related]
9. Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.
Lu F; Chen Y; Zhao C; Wang H; He D; Xu L; Wang J; He X; Deng Y; Lu EE; Liu X; Verma R; Bu H; Drissi R; Fouladi M; Stemmer-Rachamimov AO; Burns D; Xin M; Rubin JB; Bahassi EM; Canoll P; Holland EC; Lu QR
Cancer Cell; 2016 May; 29(5):669-683. PubMed ID: 27165742
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation state of Olig2 regulates proliferation of neural progenitors.
Sun Y; Meijer DH; Alberta JA; Mehta S; Kane MF; Tien AC; Fu H; Petryniak MA; Potter GB; Liu Z; Powers JF; Runquist IS; Rowitch DH; Stiles CD
Neuron; 2011 Mar; 69(5):906-17. PubMed ID: 21382551
[TBL] [Abstract][Full Text] [Related]
11. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
12. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.
Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I
Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805
[TBL] [Abstract][Full Text] [Related]
13. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
[TBL] [Abstract][Full Text] [Related]
14. Expression of TIP-1 confers radioresistance of malignant glioma cells.
Han M; Wang H; Zhang HT; Han Z
PLoS One; 2012; 7(9):e45402. PubMed ID: 23028987
[TBL] [Abstract][Full Text] [Related]
15. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
[TBL] [Abstract][Full Text] [Related]
16. Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline.
Carrasco-Garcia E; Arrizabalaga O; Serrano M; Lovell-Badge R; Matheu A
Aging Cell; 2015 Aug; 14(4):710-4. PubMed ID: 25990896
[TBL] [Abstract][Full Text] [Related]
17. A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2.
Zhou J; Tien AC; Alberta JA; Ficarro SB; Griveau A; Sun Y; Deshpande JS; Card JD; Morgan-Smith M; Michowski W; Hashizume R; James CD; Ligon KL; Snider WD; Sicinski P; Marto JA; Rowitch DH; Stiles CD
Cell Rep; 2017 Mar; 18(13):3167-3177. PubMed ID: 28355568
[TBL] [Abstract][Full Text] [Related]
18. Brain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells.
Nazarenko I; Hedrén A; Sjödin H; Orrego A; Andrae J; Afink GB; Nistér M; Lindström MS
PLoS One; 2011 Apr; 6(4):e18303. PubMed ID: 21490965
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice.
Wang J; Shen T; Zhu W; Dou L; Gu H; Zhang L; Yang Z; Chen H; Zhou Q; Sánchez ER; Field LJ; Mayo LD; Xie Z; Xiao D; Lin X; Shou W; Yong W
J Biol Chem; 2018 Nov; 293(47):18218-18229. PubMed ID: 30262665
[TBL] [Abstract][Full Text] [Related]
20. EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.
Burel-Vandenbos F; Benchetrit M; Miquel C; Fontaine D; Auvergne R; Lebrun-Frenay C; Cardot-Leccia N; Michiels JF; Paquis-Flucklinger V; Virolle T
J Neurooncol; 2011 Apr; 102(2):171-8. PubMed ID: 20652725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
